Davood Bashash
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Immunology top 5%
- Immune Response and Inflammation
Papers in
-
- Retinoids in leukemia and cellular processes 26
- PI3K/AKT/mTOR signaling in cancer 18
- Protein Degradation and Inhibitors 9
- Oncology 38
- Cancer Immunotherapy and Biomarkers 12
- Co-authors
- Atieh Pourbagheri‐Sigaroodi (58 shared papers)Seyed H. Ghaffari (58 shared papers)Ava Safaroghli‐Azar (42 shared papers)Hassan Abolghasemi (18 shared papers)Majid Momeny (33 shared papers)Mohammad‐Javad Sanaei (16 shared papers)Amir‐Mohammad Yousefi (23 shared papers)Farkhondeh Asadi (5 shared papers)
- Journals
- European Journal of Pharmacology (14 papers)International Immunopharmacology (11 papers)The International Journal of Biochemistry & Cell Biology (8 papers)IUBMB Life (5 papers)Anti-Cancer Drugs (5 papers)
- Partner nations
- IranFinlandUnited States
In The Last Decade
Davood Bashash
194 papers receiving 3.8k citations
Davood Bashash's Hit Papers
Peers
Comparison fields: 5 of 148
- Cancer Research 379
- Immunology 500
- Hematology 252
- Oncology 570
- Molecular Biology 1.5k
Countries citing papers authored by Davood Bashash
This map shows the geographic impact of Davood Bashash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davood Bashash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davood Bashash more than expected).
Fields of papers citing papers by Davood Bashash
This network shows the impact of papers produced by Davood Bashash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davood Bashash. The network helps show where Davood Bashash may publish in the future.
Co-authors
The 25 scholars most cited alongside Davood Bashash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 206 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 170 | |
| 2 | The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles Hit paper breakdown → | 2022 | 145 |
| 3 | 2020 | 143 | |
| 4 | A comprehensive review of highly pathogenic avian influenza (HPAI) H5N1: An imminent threat at doorstep Hit paper breakdown → | 2023 | 119 |
| 5 | 2021 | 109 | |
| 6 | 2021 | 103 | |
| 7 | 2022 | 80 | |
| 8 | 2021 | 80 | |
| 9 | 2016 | 79 | |
| 10 | 2020 | 78 | |
| 11 | 2020 | 66 | |
| 12 | 2021 | 64 | |
| 13 | 2020 | 59 | |
| 14 | 2016 | 51 | |
| 15 | 2019 | 50 | |
| 16 | 2019 | 48 | |
| 17 | 2024 | 47 | |
| 18 | 2021 | 46 | |
| 19 | 2011 | 44 | |
| 20 | 2021 | 40 |
About Davood Bashash
Davood Bashash is a scholar working on Molecular Biology, Oncology, Immunology, Hematology and Epidemiology, having authored 206 papers that have together received 3.8k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (26 papers), PI3K/AKT/mTOR signaling in cancer (18 papers), Acute Myeloid Leukemia Research (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), COVID-19 Clinical Research Studies (10 papers), Immune cells in cancer (10 papers), MicroRNA in disease regulation (9 papers) and Protein Degradation and Inhibitors (9 papers). The work is most often cited by research in Cancer Research (379 citations), Immunology (500 citations), Hematology (252 citations), Oncology (570 citations) and Molecular Biology (1.5k citations). Davood Bashash has collaborated with scholars based in Iran, Finland and United States. Frequent co-authors include Atieh Pourbagheri‐Sigaroodi, Seyed H. Ghaffari, Ava Safaroghli‐Azar, Hassan Abolghasemi, Majid Momeny, Mohammad‐Javad Sanaei, Amir‐Mohammad Yousefi, Farkhondeh Asadi, Mustafa Ghaderzadeh and Kamran Alimoghaddam. Their work appears in journals such as European Journal of Pharmacology, International Immunopharmacology, The International Journal of Biochemistry & Cell Biology, IUBMB Life and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.